Another China Player To Watch? Sinocare Moves Into US Via Nipro Deal
This article was originally published in PharmAsia News
Sinocare Group, a Chinese specialist in biosensor-based blood glucose monitoring devices, is expanding into the US market after agreeing to buy Nipro’s diabetes business, Nipro Diagnostics.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.